David KAUFMAN
3Patents
1h-index
11Co-inventors
37Inventor score
Filing activity: May 26, 2016 → Aug 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10751412B2 | Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer | Chemistry; Metallurgy | 3 | Active |
| US11052065B2 | Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonist | Human Necessities | 0 | Active |
| US11918648B2 | Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.